A Quantitative Systems Pharmacology Model of the Incretin Hormones GIP and GLP1, Glucagon, Glucose, Insulin, and the Small Molecule DPP-4 Inhibitor, Linagliptin-Reference-Cited by-同舟云学术

A Quantitative Systems Pharmacology Model of the Incretin Hormones GIP and GLP1, Glucagon, Glucose, Insulin, and the Small Molecule DPP-4 Inhibitor, Linagliptin

Published:2024-01 Issue:1 Volume:113 Page:278-289
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Wu Nan,An Guohua^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference45 articles.

1. A gastric inhibitory polypeptide. I. The amino acid composition and the tryptic peptides;Brown;Can J Biochem,1971

2. The place of dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapeutics: a “me too” or “the special one” antidiabetic class?;Godinho;J Diabetes Res,2015

3. Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide;Deacon;J Clin Endocrinol Metab,2000

5. Pharmacology, physiology, and mechanisms of incretin hormone action;Campbell;Cell Metab,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in physiologically based pharmacokinetic-pharmacodynamic models of amino acids in humans;Current Opinion in Clinical Nutrition & Metabolic Care;2024-08-05

2. Evaluating the Importance of Glucagon in the Insulin-Glucose Regulatory System: A Mechanistic Modeling Approach;2024-08-01